Target intelligence / Profile preview

Small intestinal immune system (GALT)

Target
GALT
Molecular classification
Other
01

Overview

The small intestinal immune system, primarily organized as gut-associated lymphoid tissue (GALT), represents a sophisticated immunological network tasked with maintaining homeostasis at the body's largest mucosal surface. It functions by balancing the active exclusion of pathogens with the induction of oral tolerance toward dietary antigens and the commensal microbiome (Mowat, 2003). Anatomically, it consists of organized lymphoid tissues like Peyer's patches and mesenteric lymph nodes, alongside diffuse effector cells in the lamina propria and epithelium (Mowat & Agace, 2014). Pathological activation of this system underlies major gastrointestinal disorders, including Crohn's disease and Celiac disease, characterized by a breakdown in tolerance and chronic inflammation (Neurath, 2014). From a drug development perspective, the system is not a single target but a site of action for numerous biologics and small molecules that target specific cytokines or cell-surface receptors to control leukocyte recruitment and inflammatory signaling (Feagan et al., 2013).

Other names
Gut-associated lymphoid tissueIntestinal mucosal immune systemGALTSmall intestine immune system
02

Mechanism of action

Modulation of lymphocyte trafficking, neutralization of pro-inflammatory cytokines, and induction of immune tolerance.

03

Biological functions

Immune responseMucosal immunityTolerance inductionPathogen defense
04

Disease associations

Inflammatory bowel diseaseCrohn's diseaseCeliac diseaseFood allergyInfection
05

Safety considerations

Systemic immunosuppressionIncreased risk of opportunistic infectionsPotential for malignancyLoss of oral tolerance
06

Interacting drugs

Vedolizumab

4 more in the full profile.

07

Biomarkers

Fecal calprotectinC-reactive proteinAnti-Saccharomyces cerevisiae antibodies (ASCA)

Beyond the preview

Go deeper on Small intestinal immune system (GALT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small intestinal immune system (GALT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call